Category: Diabetes News

Here are the top news articles that I came across this past week in the diabetes world.

Rush Introduces Insulin Access For All Bill

Today, U.S. Representative Bobby L. Rush (D-Ill.) introduced H.R.366, the Insulin Access for All Act of 2019.  This bill, cosponsored by 33 members of the Democratic Caucus, eliminates the cost sharing requirement under Medicare and Medicaid for insulin. – Read the whole article here.

Does this common food additive stop us exercising?

A two-part study that examined both mice and humans revealed a strong link between inorganic phosphate, a food additive that is prevalent in the “Western diet,” and a lack of physical activity. – Read the whole article here.

CES 2019: Running list of health tech announcements

This is a running list of digital health products announced at CES. The list will be updated as the week goes on. – Read the whole article here.

As Hospitals Post Sticker Prices Online, Most Patients Will Remain Befuddled

As of Jan. 1, in the name of transparency, the Trump administration required that all hospitals post their list prices online. But, does it have any effect? Read the whole article here.

Beta Bionics raises $63m for bionic pancreas

Boston-based Beta Bionics said this week that it closed a $63 million Series B round to support the development of its iLet bionic pancreas system for people with Type 1 diabetes. – Read the whole article here.

Here is a recap of all the Diabetes News-worthy articles I stumbled upon this week.

PATIENT EXPERIENCE FIVE TIMES AS LIKELY TO DRIVE CONSUMER LOYALTY AS MARKETING

Patient experience is five times more likely to influence brand loyalty than conventional marketing tools such as billboards, or television, print, or radio ads, the report says.

EHR Use Helps to Reduce Hospital Readmissions, Length of Stays

Research suggests hospitals engaging in EHR use to fulfill federal regulations achieve improvements in patient health outcomes.

5 Things to Know About the ADA 2019 Standards of Care

Throughout 2018, leaders in diabetes care have emphasized how disease management prevents cardiovascular events, and this was reflected in the latest Standards of Care. Here are 5 things to know about the ADA Standards of Care

GLP-1 Receptor Agonists Not Associated With Increased Diabetic Retinopathy Risk

Use of glucagon-like peptide 1 (GLP-1) receptor agonists does not increase risk for diabetic retinopathy in older adults, according to study results published in Diabetes Care.